Third Rock Ventures II, L.P. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Third Rock Ventures II, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Third Rock Ventures II, L.P.. Third Rock Ventures II, L.P. is a 10% Owner in MyoKardia Inc ($MYOK) and a 10% Owner in Blueprint Medicines Corp ($BPMC) and a 10% Owner in Sage Therapeutics, Inc. ($SAGE) and a 10% Owner in Allena Pharmaceuticals, Inc. ($ALNA) and a 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and a 10% Owner in Jounce Therapeutics, Inc. ($JNCE) and a 10% Owner in Revolution Medicines, Inc. ($RVMD).
Over the past year Third Rock Ventures II, L.P. has been an insider in 2 companies. The total value of shares held by Third Rock Ventures II, L.P. in these companies amounts to $76,947,442.
Insider Rank
Third Rock Ventures II, L.P. ranks 96 out of 350,000 insiders. Go to Insider Ranking to see more.
Address: 29 NEWBURY STREET, 3RD FLOOR BOSTON 02116 MA
Companies in which Third Rock Ventures II, L.P. is an Insider
Allena Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 2,575,964 shares
Latest Transaction: Nov 06 2017
Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions
Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 2,790,964
Shares Sold: 0
Share Difference: +2,790,964
Value Difference: -$3,010,000
Blueprint Medicines Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 4,453,753 shares
Current Value: $159,622,508
Latest Transaction: Feb 09 2017
$BPMC Market Capitalization: $979.55M
$BPMC Previous Close: $35.84
Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions
Last 3 Months Overview:
Buy: 0x
Sell: 2x
Shares Bought: 0
Shares Sold: 2,200,000
Share Difference: -2,200,000
Value Difference: +$35,275,000
Global Blood Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 2,475,191 shares
Current Value: $40,098,094
Latest Transaction: Jun 16 2017
$GBT Market Capitalization: $626.91M
$GBT Previous Close: $16.20
Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions
Last 3 Months Overview:
Buy: 0x
Sell: 14x
Shares Bought: 0
Shares Sold: 12,097,002
Share Difference: -12,097,002
Value Difference: +$90,965,476
Jounce Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 4,447,829 shares
Current Value: $76,947,442
Latest Transaction: Jun 14 2021
$JNCE Market Capitalization: $140.99M
$JNCE Previous Close: $17.30
Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions
Last 3 Months Overview:
Buy: 2x
Sell: 4x
Shares Bought: 12,737,124
Shares Sold: 3,765,000
Share Difference: +8,972,124
Value Difference: +$108,773
MyoKardia, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 885,104 shares
Current Value: $10,621,248
Latest Transaction: Mar 07 2018
$MYOK Market Capitalization: $375.56M
$MYOK Previous Close: $12.00
Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions
Last 3 Months Overview:
Buy: 0x
Sell: 10x
Shares Bought: 0
Shares Sold: 8,522,650
Share Difference: -8,522,650
Value Difference: +$34,997,779
Revolution Medicines, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 1,774,317 shares
Latest Transaction: May 27 2021
Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions
Last 3 Months Overview:
Buy: 0x
Sell: 2x
Shares Bought: 0
Shares Sold: 1,366,204
Share Difference: -1,366,204
Value Difference: +$41,764,208
Sage Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 2,892,916 shares
Current Value: $137,992,093
Latest Transaction: Aug 19 2016
$SAGE Market Capitalization: $1.75B
$SAGE Previous Close: $47.70
Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions
Last 3 Months Overview:
Buy: 0x
Sell: 2x
Shares Bought: 0
Shares Sold: 1,850,000
Share Difference: -1,850,000
Value Difference: +$26,562,500
Latest Insider Trading Transactions of Third Rock Ventures II, L.P.
Sentiment: All, ALNA, BPMC, GBT, JNCE, MYOK, RVMD, SAGE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,500,000 | 0 | 4,447,829 | 5.9 M to 4.4 M (-25.22 %) |
| May 27 2021 | RVMD | Revolution Medicin ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 30.53 | 1,231,204 | 37,588,658 | 543,113 | 1.8 M to 543.1 K (-69.39 %) |
| May 27 2021 | RVMD | Revolution Medicin ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 30.93 | 135,000 | 4,175,550 | 1,774,317 | 1.9 M to 1.8 M (-7.07 %) |
| Mar 15 2021 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,250,000 | 0 | 6,500,349 | 7.8 M to 6.5 M (-16.13 %) |
| Nov 19 2020 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 7.25 | 15,000 | 108,773 | 9,215,349 | 9.2 M to 9.2 M (-0.16 %) |
| Nov 13 2020 | JNCE | Jounce Therapeutic ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 9,230,349 | 10.2 M to 9.2 M (-9.77 %) |
| Mar 07 2018 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 885,104 | 2.9 M to 885.1 K (-69.32 %) |